Author's posts
Raffles Medical Group Sees China On The Mend From Covid As Its Expansion Continues
Raffles Medical Group from Singapore plans to increase the number of cities it serves in China from the current eight to 20 in the next three to five years.
U.S. Cancer Moonshot Needs Stronger Int’l Effort To Make Substantial Progress – Kevin Rudd
“International trials have been key to accelerating the breakthroughs that we’ve seen so far,” Rudd told the Forbes China Healthcare Summit
From Patient To Policy Insider: Greg Simon’s Cancer Rx Includes A Better White House Rallying Call
The “Cancer Moonshot” should be renamed “Human Moonshot” as part of a true global effort, Simon tells Forbes China Healthcare Forum
Shanghai-Based Pharma Business Breaks Ground On Delaware Facility
Site is expected to employ 500 people by 2026
U.S. Research Grants Should Require Data Sharing: Cancer Moonshot Pathways
“Today, the way we get big data is: ‘You’ve got your pile and I’ve got my pile.’ If we curate a combined pile into a synthetic larger pile, that’s where it starts getting very useful.”
Curing Cancer Takes A Global Village: Cancer Moonshot Pathways
Expanding international participation in drug trials will bring treatments to patients faster, BeiGene CEO John. V. Oyler says
Social Justice, Outreach, Global Collaboration: Cancer Moonshot Pathways
“If there is one thing the new Moonshot should do,” says Greg Simon, the inaugural executive director of the White House Cancer Moonshot “it is focus on social justice in the distribution of the treatments, cures and screening.”
Innovative Solutions To Cancer Require Innovative Finance: Cancer Moonshot Pathways
“Imagine if the government issued cancer bonds,” says MIT Finance Professor Andrew W. Lo
Close The Gap Between Discovery Research And Patient Care: Cancer Moonshot Pathways
“In the field of cancer therapeutics, there’s a growing divide between discovery and delivery” says Novartis Global Program Head for Lung Cancer Andrea Myers
Biden Deserves Credit For Taking On Cancer: Cancer Moonshot Pathways
Immunotherapy, precision medicine, equity offer room for gains, incoming MSK CEO says
